356 related articles for article (PubMed ID: 17705973)
1. Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children.
Thee S; Detjen A; Quarcoo D; Wahn U; Magdorf K
Int J Tuberc Lung Dis; 2007 Sep; 11(9):965-71. PubMed ID: 17705973
[TBL] [Abstract][Full Text] [Related]
2. Rifampicin serum levels in childhood tuberculosis.
Thee S; Detjen A; Wahn U; Magdorf K
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1106-11. PubMed ID: 19723399
[TBL] [Abstract][Full Text] [Related]
3. Ethambutol dosage for the treatment of children: literature review and recommendations.
Donald PR; Maher D; Maritz JS; Qazi S
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1318-30. PubMed ID: 17167947
[TBL] [Abstract][Full Text] [Related]
4. Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature.
Trébucq A
Int J Tuberc Lung Dis; 1997 Feb; 1(1):12-5. PubMed ID: 9441051
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
[TBL] [Abstract][Full Text] [Related]
6. [Study of the ocular toxicity of ethambutol].
Nagy A; Fodor F; Avéd N; Chiriţă-Páll E; Szabó I
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1980; 29(3):163-6. PubMed ID: 6254129
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses.
Ahmad Z; Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2006 May; 27(5):409-16. PubMed ID: 16624533
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
Zítková L; Janků I; Tousek J; Papezová E; Stastná J
Czech Med; 1983; 6(4):202-17. PubMed ID: 6420125
[TBL] [Abstract][Full Text] [Related]
10. Pyrazinamide serum levels in childhood tuberculosis.
Thee S; Detjen A; Wahn U; Magdorf K
Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
[TBL] [Abstract][Full Text] [Related]
11. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease.
Griffith DE; Brown-Elliott BA; Shepherd S; McLarty J; Griffith L; Wallace RJ
Am J Respir Crit Care Med; 2005 Jul; 172(2):250-3. PubMed ID: 15860751
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics and pharmacodynamics of rifampicin in adults and children in relation to the dosage recommended for children.
Donald PR; Maritz JS; Diacon AH
Tuberculosis (Edinb); 2011 May; 91(3):196-207. PubMed ID: 21429802
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania.
Justine M; Yeconia A; Nicodemu I; Augustino D; Gratz J; Mduma E; Heysell SK; Kivuyo S; Mfinanga S; Peloquin CA; Zagurski T; Kibiki GS; Mmbaga B; Houpt ER; Thomas TA
J Pediatric Infect Dis Soc; 2020 Feb; 9(1):14-20. PubMed ID: 30395239
[TBL] [Abstract][Full Text] [Related]
14. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
Szklo A; Mello FC; Guerra RL; Dorman SE; Muzy-de-Souza GR; Conde MB
Int J Tuberc Lung Dis; 2007 Jul; 11(7):775-80. PubMed ID: 17609053
[TBL] [Abstract][Full Text] [Related]
15. Isoniazid pharmacokinetic studies of the 1960s: considering a higher isoniazid dose in childhood tuberculosis.
Thee S; Detjen AA; Wahn U; Magdorf K
Scand J Infect Dis; 2010 Apr; 42(4):294-8. PubMed ID: 20100111
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
Verhagen LM; López D; Hermans PW; Warris A; de Groot R; García JF; de Waard JH; Aarnoutse RE
Trop Med Int Health; 2012 Dec; 17(12):1449-56. PubMed ID: 23094704
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of tuberculosis--compliance, side effects and incidence of recurrence].
Brändli O; Häcki MA; Scheel A; Stiefel M
Schweiz Med Wochenschr; 1983 Jan; 113(3):92-6. PubMed ID: 6828844
[TBL] [Abstract][Full Text] [Related]
18. Ethambutol-related impaired visual function in childrens less than 5 years of age treated for a mycobacterial infection: diagnosis and evolution.
Levy M; Rigaudière F; de Lauzanne A; Koehl B; Melki I; Lorrot M; Faye A
Pediatr Infect Dis J; 2015 Apr; 34(4):346-50. PubMed ID: 25764095
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug.
Jia L; Tomaszewski JE; Hanrahan C; Coward L; Noker P; Gorman G; Nikonenko B; Protopopova M
Br J Pharmacol; 2005 Jan; 144(1):80-7. PubMed ID: 15644871
[TBL] [Abstract][Full Text] [Related]
20. Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels.
Um SW; Lee SW; Kwon SY; Yoon HI; Park KU; Song J; Lee CT; Lee JH
Int J Tuberc Lung Dis; 2007 Sep; 11(9):972-8. PubMed ID: 17705974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
